With increased regulatory scrutiny, pricing and cost pressures, as well as the rapid developments in genomic technology leading to a more personalised approach to medicine and healthcare, businesses and organisations in the life sciences and healthcare sector face a growing number of complex legal and regulatory challenges in order to stay competitive.
Our International Life Sciences & Healthcare group works with over 50% of the world’s largest pharmaceutical, biotechnology and medical devices companies. We have the largest patent litigation group in Europe and are recognised by major global directories as a top tier life sciences firm.
Our focus on business being changed by technology and the digital world enables us to support our clients operating in this rapidly changing environment. Our multidisciplinary team of 240 specialist life sciences and healthcare lawyers worldwide can advise you on every aspect of the business cycle of a life science and healthcare product or service, from incorporation through development to protection and exploitation of intellectual property.
We can advise you on:
If you would like to know more about how we can help your business, please contact Heads of Group: Marc Martens in Brussels and Mark Hilton in London.
Chambers UK, 2018
Chambers Europe-wide, 2018
Legal 500, 2018
Chambers Asia-Pacific, 2018
Chambers Global- wide, 2018
Bird & Bird advised AddLife in its acquisition of all shares in the Danish companies Lab-Vent Controls A/S and Koldt & Ryø El A/S.
On 20 April 2019, the Standing Committee of the National People's Congress ("NPC") held a second deliberation meeting to discuss the Draft Amendments to Drug Administration Law ("Second Draft DAL Amendments"). A week ...
In this month's report, we look at the Court of Justice's decision on colour combinations in Red Bull GmbH (supported by Marques) v EUIPO, Optimum Mark sp. z o.o. C-124/18. We also look at the Court of Justice's ...
International law firm Bird & Bird today announces the merger of its Baseline consulting arm with Valeocon Management Consulting, creating one of the largest management consultancy firms linked to an international law ...
International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")
International law firm Bird & Bird advises the FUJIFILM group on the acquisition of German medwork GmbH, a company that develops, manufactures and markets instruments for therapeutic and diagnostic endoscopy.
Partner for a Day is your opportunity to gain insights into the work of a lawyer. You will get two days of legal training with workshops and cases in e.g. contract drafting and negotiation techniques.
When do clinical trial consent disclosures render a patent invalid? https://t.co/7PjQvZoQfL https://t.co/Peg4Eg7mzI
RT @twobirds: On the day that the UK welcomes a new PM - Partner @twobirdsIP @SallyShorthose greets guests to our #Brexit Update in our Lon…
RT @twobirdsFR: Nouveau régime français d'IP box : retrouvez l'article co-écrit par notre associée @ClotLaurence et @BrentSpringael dans l…